Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.

Veterinary and comparative oncology - 1 Mar 2022

Wang Guannan, Wu Ming, Durham Amy C, Mason Nicola J, Roth David B

Abstract excerpt

Canine cancer, a significant cause of mortality in domestic dogs, is a powerful comparative model for human cancers. Revealing genetic alterations driving the oncogenesis of canine cancers holds great potential to deepen our understanding of the cancer biology, guide therapeutic development, and improve cancer management in both dogs and people. Next generation sequencing (NGS) based-diagnostic panels have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Dog Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 34286913
DOI: 10.1111/vco.12746

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.PMID 34286913Read ↗

Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.Semantic proximity Read ↗

Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogsSemantic proximity Read ↗

The Genetic Landscape of Canine Tumors: Insights from the Canine Cancer Genome Atlas (CCGA)Semantic proximity Read ↗

Leading the pack: Best practices in comparative canine cancer genomics to inform human oncologySemantic proximity Read ↗

Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.Semantic proximity Read ↗

The shared selection landscape of dog and human cancersSemantic proximity Read ↗

The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classificationSemantic proximity Read ↗

Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome SequencingSemantic proximity Read ↗

Consensus-based somatic variant-calling method correlates <i>FBXW7</i> mutations with poor prognosis in canine B-cell lymphomaSemantic proximity Read ↗

Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in DogsSemantic proximity Read ↗

Leveraging Dog Models to Uncover Human Cancer InsightsSemantic proximity Read ↗

Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and FutureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.